MARLBOROUGH, Mass.,
Aug. 1, 2016 /PRNewswire/ -- Boston
Scientific Corporation (NYSE: BSX) is scheduled to participate in
the 36th Annual Canaccord Genuity Growth Conference on
August 11 in Boston and the 2016 Wedbush PacGrow Healthcare
Conference on August 16 in
New York.
Susie Lisa, vice president, and
Justin Castelli, senior manager,
Investor Relations, will participate in a 25-minute
question-and-answer session with the Canaccord Genuity host analyst
beginning at approximately 8:30 a.m.
ET on August 11, and a
30-minute question-and-answer session with the Wedbush PacGrow host
analyst beginning at approximately 10:20
a.m. ET on August 16.
Live webcasts of both question-and-answer sessions will be
available on the Investor Relations section of the Boston
Scientific website at www.bostonscientific.com/investors.
Interested parties are encouraged to register at least 15
minutes prior to the scheduled start times to ensure a timely
connection.
A replay of each webcast will be accessible at
www.bostonscientific.com/investors beginning approximately one hour
following the completion of the event.
About Boston Scientific
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world. As a global medical technology leader for more than 35
years, we advance science for life by providing a broad range of
high performance solutions that address unmet patient needs and
reduce the cost of healthcare. For more information, visit
www.bostonscientific.com and connect on Twitter and Facebook.
CONTACTS
|
|
Media:
|
Investors:
|
Tom
Keppeler
|
Susie Lisa,
CFA
|
508-683-6585
(office)
|
508- 683-5565
(office)
|
Media
Relations
|
Investor
Relations
|
Boston Scientific
Corporation
|
Boston Scientific
Corporation
|
thomas.keppeler@bsci.com
|
investor_relations@bsci.com
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/boston-scientific-to-participate-in-canaccord-genuity-growth-conference-and-wedbush-pacgrow-healthcare-conference-300306492.html
SOURCE Boston Scientific Corporation